Alnylam Pharmaceuticals IncALNY | $6.7M20.9k shares | SellMar 5, 2026 | $75.3K233 shares | $323.25 | -- |
Alnylam Pharmaceuticals IncALNY | $6.7M20.6k shares | SellMar 5, 2026 | $49.9K153 shares | $326.24 | -- |
Alnylam Pharmaceuticals IncALNY | $6.7M20.7k shares | SellMar 5, 2026 | $48.0K148 shares | $324.60 | -- |
Alnylam Pharmaceuticals IncALNY | $6.8M21.1k shares | SellMar 5, 2026 | $39.9K124 shares | $321.81 | -- |
Alnylam Pharmaceuticals IncALNY | $6.9M21.4k shares | SellMar 4, 2026 | $68.0K210 shares | $323.84 | -- |
Alnylam Pharmaceuticals IncALNY | $7.0M21.6k shares | SellMar 4, 2026 | $31.0K96 shares | $323.01 | -- |
Alnylam Pharmaceuticals IncALNY | $7.0M21.7k shares | SellMar 4, 2026 | $25.4K79 shares | $321.82 | -- |
Alnylam Pharmaceuticals IncALNY | $6.9M21.3k shares | SellMar 4, 2026 | $24.4K75 shares | $324.88 | -- |
Alnylam Pharmaceuticals IncALNY | $7.0M21.7k shares | SellMar 4, 2026 | $18.9K59 shares | $320.81 | -- |
Alnylam Pharmaceuticals IncALNY | $6.9M21.2k shares | SellMar 4, 2026 | $18.6K57 shares | $325.67 | -- |
Alnylam Pharmaceuticals IncALNY | $7.0M21.8k shares | SellMar 4, 2026 | $9.3K29 shares | $319.03 | -- |
Alnylam Pharmaceuticals IncALNY | $7.0M21.8k shares | SellMar 4, 2026 | $9.0K28 shares | $320.01 | -- |
Alnylam Pharmaceuticals IncALNY | $7.1M22.2k shares | SellMar 3, 2026 | $231.4K722 shares | $320.51 | -- |
Alnylam Pharmaceuticals IncALNY | $7.0M21.9k shares | SellMar 3, 2026 | $115.4K359 shares | $321.58 | -- |
Alnylam Pharmaceuticals IncALNY | $7.4M23.2k shares | SellMar 3, 2026 | $91.5K289 shares | $316.55 | -- |
Alnylam Pharmaceuticals IncALNY | $7.3M22.9k shares | SellMar 3, 2026 | $89.9K282 shares | $318.62 | -- |
Alnylam Pharmaceuticals IncALNY | $2.6M8.1k shares | Grant / ExerciseMar 2, 2026 | $2.6M8.1k shares | $325.07 | -- |
Alnylam Pharmaceuticals IncALNY | --25.1k shares | Grant / ExerciseMar 2, 2026 | Disclosure amount unavailable3.7k shares | -- | -- |
Alnylam Pharmaceuticals IncALNY | $7.9M24.3k shares | SellMar 2, 2026 | $128.1K392 shares | $326.81 | -- |
Alnylam Pharmaceuticals IncALNY | $7.9M24k shares | SellMar 2, 2026 | $107.8K329 shares | $327.67 | -- |
Alnylam Pharmaceuticals IncALNY | $8.0M24.7k shares | SellMar 2, 2026 | $84.0K258 shares | $325.63 | -- |
Alnylam Pharmaceuticals IncALNY | $7.8M23.7k shares | SellMar 2, 2026 | $56.1K170 shares | $329.71 | -- |
Alnylam Pharmaceuticals IncALNY | $7.9M23.9k shares | SellMar 2, 2026 | $32.9K100 shares | $328.71 | -- |
Alnylam Pharmaceuticals IncALNY | $7.8M23.5k shares | SellMar 2, 2026 | $31.2K94 shares | $331.93 | -- |
Alnylam Pharmaceuticals IncALNY | $8.1M25k shares | SellMar 2, 2026 | $29.2K90 shares | $324.65 | -- |
Alnylam Pharmaceuticals IncALNY | $7.8M23.6k shares | SellMar 2, 2026 | $26.8K81 shares | $330.85 | -- |
Alnylam Pharmaceuticals IncALNY | $8.1M25.1k shares | SellMar 2, 2026 | $15.2K47 shares | $323.62 | -- |
Alnylam Pharmaceuticals IncALNY | $7.8M23.5k shares | SellMar 2, 2026 | $12.3K37 shares | $332.64 | -- |
Ovid Therapeutics Inc.OVID | $107k65k shares | Grant / ExerciseFeb 26, 2026 | $107.3K65k shares | $1.65 | -- |
Alnylam Pharmaceuticals IncALNY | --21.4k shares | Grant / ExerciseFeb 23, 2026 | Disclosure amount unavailable158 shares | -- | -- |
Alnylam Pharmaceuticals IncALNY | $7.1M21.3k shares | SellFeb 17, 2026 | $677.5K2k shares | $331.96 | -- |
Alnylam Pharmaceuticals IncALNY | $7.2M23.3k shares | SellFeb 13, 2026 | $607.4K2k shares | $310.08 | -- |
Alnylam Pharmaceuticals IncALNY | --25.3k shares | Grant / ExerciseFeb 12, 2026 | Disclosure amount unavailable4k shares | -- | -- |
Alnylam Pharmaceuticals IncALNY | $8.6M23.4k shares | SellJan 13, 2026 | $72.4K197 shares | $367.52 | -- |
Alnylam Pharmaceuticals IncALNY | $8.8M23.6k shares | SellJan 12, 2026 | $7452 shares | $372.46 | -- |
Alnylam Pharmaceuticals IncALNY | $8.7M23.8k shares | SellJan 12, 2026 | $80.4K220 shares | $365.56 | -- |
Alnylam Pharmaceuticals IncALNY | $8.8M24.1k shares | SellJan 12, 2026 | $72.6K199 shares | $364.83 | -- |
Alnylam Pharmaceuticals IncALNY | $8.8M24.5k shares | SellJan 12, 2026 | $55.8K155 shares | $360.22 | -- |
Alnylam Pharmaceuticals IncALNY | $8.9M24.7k shares | SellJan 12, 2026 | $44.1K123 shares | $358.18 | -- |
Alnylam Pharmaceuticals IncALNY | $8.8M24.4k shares | SellJan 12, 2026 | $35.4K98 shares | $361.45 | -- |
Alnylam Pharmaceuticals IncALNY | $8.9M24.8k shares | SellJan 12, 2026 | $34.3K96 shares | $357.17 | -- |
Alnylam Pharmaceuticals IncALNY | $8.7M23.7k shares | SellJan 12, 2026 | $33.9K92 shares | $368.62 | -- |
Alnylam Pharmaceuticals IncALNY | $8.8M24.6k shares | SellJan 12, 2026 | $30.5K85 shares | $359.14 | -- |
Alnylam Pharmaceuticals IncALNY | $8.8M24.3k shares | SellJan 12, 2026 | $26.5K73 shares | $362.38 | -- |
Alnylam Pharmaceuticals IncALNY | $8.7M23.8k shares | SellJan 12, 2026 | $18.3K50 shares | $366.41 | -- |
Alnylam Pharmaceuticals IncALNY | $8.8M24.3k shares | SellJan 12, 2026 | $17.1K47 shares | $363.55 | -- |
Alnylam Pharmaceuticals IncALNY | $8.7M23.8k shares | SellJan 12, 2026 | $15.1K41 shares | $367.40 | -- |
Alnylam Pharmaceuticals IncALNY | $8.9M25k shares | SellJan 12, 2026 | $14.9K42 shares | $355.16 | -- |
Alnylam Pharmaceuticals IncALNY | $8.7M23.6k shares | SellJan 12, 2026 | $14.8K40 shares | $369.48 | -- |
Alnylam Pharmaceuticals IncALNY | $8.9M24.9k shares | SellJan 12, 2026 | $14.6K41 shares | $356.09 | -- |
Alnylam Pharmaceuticals IncALNY | $8.9M25k shares | SellJan 12, 2026 | $13.8K39 shares | $353.95 | -- |
Alnylam Pharmaceuticals IncALNY | $8.9M23.6k shares | SellJan 12, 2026 | $7.1K19 shares | $375.65 | -- |
Alnylam Pharmaceuticals IncALNY | $8.8M23.6k shares | SellJan 12, 2026 | $7.0K19 shares | $370.87 | -- |
Alnylam Pharmaceuticals IncALNY | $8.9M23.6k shares | SellJan 12, 2026 | $5.7K15 shares | $377.82 | -- |
Alnylam Pharmaceuticals IncALNY | $8.8M23.6k shares | SellJan 12, 2026 | $5.2K14 shares | $374.44 | -- |
Alnylam Pharmaceuticals IncALNY | --25.1k shares | Grant / ExerciseJan 11, 2026 | Disclosure amount unavailable3.8k shares | -- | -- |
Ovid Therapeutics Inc.OVID | $26k45k shares | Grant / ExerciseFeb 20, 2025 | $25.6K45k shares | $0.57 | -- |
Ovid Therapeutics Inc.OVID | $95k90k shares | Grant / ExerciseDec 12, 2024 | $95.4K90k shares | $1.06 | -- |